Patricia Colvin - Bionoid Pharma Director Controller

All Insiders . USA . 
Stock . Bionoid Pharma . Stakeholders . Insider . Patricia Colvin
BINP Stock  USD 0.14  0.01  6.67%   

Insider

Patricia Colvin is Director Controller of Bionoid Pharma
Phone800 784 7641
Webhttps://bionoidpharma.com

Bionoid Pharma Management Efficiency

The company has return on total asset (ROA) of (1.6412) % which means that it has lost $1.6412 on every $100 spent on assets. This is way below average. Bionoid Pharma's management efficiency ratios could be used to measure how well Bionoid Pharma manages its routine affairs as well as how well it operates its assets and liabilities.
Bionoid Pharma currently holds 64.5 K in liabilities. Bionoid Pharma has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bionoid Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Bionoid Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bionoid Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bionoid to invest in growth at high rates of return. When we think about Bionoid Pharma's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Kelly YuZW Data Action
N/A
James SightGriffon
65
Ti WuZhongAn Online P
46
Yingguo GuoZW Data Action
N/A
Peregrine RiviereWPP PLC ADR
N/A
Julie PattersonNational CineMedia
N/A
Mary HoweWPP PLC ADR
N/A
Thomas IlubeWPP PLC ADR
N/A
Jennifer RemlingWPP PLC ADR
N/A
Simon DingemansWPP PLC ADR
N/A
Cheryl TurnbullGriffon
60
Yongbo ZhangZhongAn Online P
45
Mingyu ChangZW Data Action
N/A
Ruimin DengZhongAn Online P
N/A
Jonathan ChevalierCimpress NV
N/A
Sugandha KhandelwalFluent Inc
43
Balbir KellyBislaWPP PLC ADR
N/A
Rob ReillyWPP PLC ADR
N/A
Florian BaumgartnerCimpress NV
46
Dave KupiecNational CineMedia
N/A
Jacqui CanneyWPP PLC ADR
N/A
Bionoid Pharma Inc. engages in the hemp cultivation business. Bionoid Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people. Bionoid Pharma [BINP] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Return On Asset-1.64

Bionoid Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Bionoid Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset-1.64
Operating Margin(4.22) %
Current Valuation3.81 M
Shares Outstanding42.28 M
Price To Sales540.76 X
Revenue92.26 K
Gross Profit47.48 K
EBITDA(385.71 K)
Net Income(1.62 M)
Cash And Equivalents127

Pair Trading with Bionoid Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionoid Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Bionoid Pink Sheet

  0.62TAK Takeda PharmaceuticalPairCorr
  0.49TKPHF Takeda PharmaceuticalPairCorr
  0.47HLNCF Haleon plcPairCorr
  0.47EC Ecopetrol SA ADRPairCorr
  0.44HLN Haleon plc Buyout TrendPairCorr
The ability to find closely correlated positions to Bionoid Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionoid Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionoid Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionoid Pharma to buy it.
The correlation of Bionoid Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bionoid Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bionoid Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bionoid Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Bionoid Pink Sheet Analysis

When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY